Screener
Monopar Therapeutics MNPR Q2 2026 earnings
Reported August 12, 2026 · Before market open
EPS-$0.62Beat by $0.02
EPS estimate-$0.64
Next report
Nov 12, 2026 (in a month)EPS estimate-$0.86
Versus estimates
Diluted EPS
FAQ
- When did Monopar Therapeutics report Q2 2026 earnings?
- Monopar Therapeutics (MNPR) reported Q2 2026 earnings on August 12, 2026 before market open.
- What were Monopar Therapeutics's Q2 2026 revenue and EPS?
- Monopar Therapeutics reported eps of $-0.62 for Q2 2026.
- Did Monopar Therapeutics beat estimates in Q2 2026?
- EPS beat the consensus estimate of $-0.64 by $0.02.
- How did Monopar Therapeutics's Q2 2026 results compare year-over-year?
- Compared to the same quarter a year prior, eps declined 77.1% from $-0.35.
- Where can I find Monopar Therapeutics's Q2 2026 SEC filings?
- You can read the 8-K earnings release (0001437749-26-027165) and the 10-Q periodic report (0001437749-26-027164) directly on SEC EDGAR. The filing index links above go to sec.gov.
